Given the accelerating global momentum in CAR-T and gene therapies, ProBio Inc. and Curocell have achieved a significant ...

Announcing a new publication from Opto-Electronic Advances; DOI 10.29026/oea.2026.250303. SHANNON, CLARE, IRELAND, ...

Announcing a new publication from Opto-Electronic Advances; DOI 10.29026/oea.2026.250303 .In the digital age, information security has become the ...

Nocion Therapeutics, Inc., a biopharmaceutical company developing novel small molecule therapies that selectively silence activated sensory neurons, today announced that its Phase 2b ASPIRE trial ...

The leukaemia treatment medication obtained through public donations for a female patient from Limbang, Sarawak, will be ...

Steel Authority of India Limited (SAIL) intends to reduce its contract workforce by 40% from April 2025 levels, completing the process by the end of FY27, following Ministry of Steel guidance. An ...

Darzalex and new launches fuel J&J's 17.8% oncology sales growth in Q1 as the company targets $50B in cancer sales by 2030.

Black, Hispanic and female patients with ulcerative colitis were significantly less likely to undergo colectomy compared with ...

What actually determines a home's true market value when online home value estimates seem to provide an instant answer? A newly published feature, a HelloNation article, explains why a quick number ...

Sitka Reports 94.3% Gold Recovery And 84.7% Tungsten Recovery From Metallurgical Testing At The Rhosgobel Deposit At Its Rc ...

Ghent, Belgium, 28 April 2026 - Sequana Medical NV(Euronext Brussels: SEQUA) (the "Company" or "SequanaMedical"), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart ...

Good afternoon, everyone, and welcome to Gilead's First Quarter 2026 Earnings Conference Call. My name is Rebecca, and I'll be today's host. [Operator Instructions] Now I'll hand the call over to ...